Episode Details
Back to EpisodesCOVID-19 clinical update #53 with Dr. Daniel Griffin
Episode 730
Published 4 years, 10 months ago
Description
In COVID-19 clinical update #53, Daniel Griffin reviews underreporting of infections and long term disease in children, a blood test for T cells, results of phase 3 trials for monoclonal antibodies, preliminary findings on an oral antiviral, clinical trial of ivermectin, and recommendations for upcoming gatherings.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- SARS-CoV-2 seroprevalence in <18 year olds (MMWR)
- EUA for T cell test (FDA)
- Lilly mAb phase 3 results (Lilly)
- VIR-7831 mAb phase 3 results (Globenewswire)
- Molnupiravir phase 2a results (Merck)
- Ivermectin not supported for mild COVID-19 (JAMA)
- Recommendations for fully vaccinated people (CDC)
- Letters read on TWiV 730
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv